Correlation Between ADC Therapeutics and Day One

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ADC Therapeutics and Day One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ADC Therapeutics and Day One into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ADC Therapeutics SA and Day One Biopharmaceuticals, you can compare the effects of market volatilities on ADC Therapeutics and Day One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ADC Therapeutics with a short position of Day One. Check out your portfolio center. Please also check ongoing floating volatility patterns of ADC Therapeutics and Day One.

Diversification Opportunities for ADC Therapeutics and Day One

0.44
  Correlation Coefficient

Very weak diversification

The 3 months correlation between ADC and Day is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding ADC Therapeutics SA and Day One Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Day One Biopharmaceu and ADC Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ADC Therapeutics SA are associated (or correlated) with Day One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Day One Biopharmaceu has no effect on the direction of ADC Therapeutics i.e., ADC Therapeutics and Day One go up and down completely randomly.

Pair Corralation between ADC Therapeutics and Day One

Given the investment horizon of 90 days ADC Therapeutics SA is expected to under-perform the Day One. In addition to that, ADC Therapeutics is 1.78 times more volatile than Day One Biopharmaceuticals. It trades about -0.05 of its total potential returns per unit of risk. Day One Biopharmaceuticals is currently generating about 0.02 per unit of volatility. If you would invest  1,350  in Day One Biopharmaceuticals on August 31, 2024 and sell it today you would earn a total of  22.00  from holding Day One Biopharmaceuticals or generate 1.63% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

ADC Therapeutics SA  vs.  Day One Biopharmaceuticals

 Performance 
       Timeline  
ADC Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ADC Therapeutics SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Day One Biopharmaceu 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Day One Biopharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Day One is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

ADC Therapeutics and Day One Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ADC Therapeutics and Day One

The main advantage of trading using opposite ADC Therapeutics and Day One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ADC Therapeutics position performs unexpectedly, Day One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will offset losses from the drop in Day One's long position.
The idea behind ADC Therapeutics SA and Day One Biopharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
FinTech Suite
Use AI to screen and filter profitable investment opportunities